Does TAFASITAMAB-CXIX Cause Diffuse large b-cell lymphoma recurrent? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with TAFASITAMAB-CXIX. This represents 0.8% of all adverse event reports for TAFASITAMAB-CXIX.
6
Reports of Diffuse large b-cell lymphoma recurrent with TAFASITAMAB-CXIX
0.8%
of all TAFASITAMAB-CXIX reports
1
Deaths
1
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From TAFASITAMAB-CXIX?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB-CXIX Cause?
Disease progression (218)
Lymphoma (158)
Off label use (126)
Death (53)
Drug ineffective (39)
Blood lactate dehydrogenase increased (34)
Diffuse large b-cell lymphoma (32)
Malignant neoplasm progression (30)
Neutropenia (30)
Polyneuropathy (29)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which TAFASITAMAB-CXIX Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
TAFASITAMAB-CXIX vs TAFINLAR
TAFASITAMAB-CXIX vs TAFLUPROST
TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS
TAFASITAMAB-CXIX vs TAHOR
TAFASITAMAB-CXIX vs TALAZOPARIB